ANN ARBOR, MI, UNITED STATES, January 7, 2025 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations, today announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration (FDA) to market its CrystLCare™ PRO Biorestorative, Fluoride-Plus product as a 510(k) Class II Medical Device.
Read More “The study reveals compelling in vitro data supporting GreenMark’s CrystLCare™ Biorestorative technology, which offers a non-invasive solution for addressing early-stage dental caries. This breakthrough research resulted from an NIH-funded collaboration of investigators at top dental schools together with the GreenMark team.”
Read More
In this study, the authors explore an alternative approach to remineralization treatment using targeted submicrometer particles (CrystLCare™ Biorestorative Fluoride-Free, Fluoride-Plus) to deliver calcium, phosphate, and fluoride preferentially to the subsurface porosities of noncavitated caries lesions. In vitro results indicated that targeted particles could improve treatment efficacy with increased subsurface mineralization, which leads to better esthetics, […]
Read More
By Arash Hakhamian, DDS, Co-Founder and CEO of Dentulu, Inc. – May 28, 2024 – Do your patients continue to be aggravated by sensitivity due to recession, bleaching, or with veneer or crown preps? Does it limit their dietary choices? Compromise their dental hygiene? Affect their quality of life? Are you still searching for a […]
Read More ANN ARBOR, MI, UNITED STATES, May 22, 2024 – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic nanotechnology for dental health innovations, proudly announces a strategic partnership with Dentulu, Inc., the leader in online preventative dental solutions. This partnership heralds the introduction of a first product, CrystLCare™ Biorestorative, Fluoride-Free, in a GreenMark-Dentulu co-branded product line, providing groundbreaking solutions designed to […]
Read More Ann Arbor, MI, May 16, 2024 – GreenMark Biomedical Inc. announces it will receive up to $200,000 in additional funding to advance its innovative regenerative technology toward products for dental sensitivity treatment and noninvasive mineralization of early-stage dental decay. To date GreenMark raised $8.6 million in equity investment and non-dilutive funding. In the final year […]
Read MoreDr. Nathan Jones, VP of Technology, presented a technical progress update at the 2024 MPWRM Resource Center Annual Stakeholder’s Summit held at the University of Michigan, Ann Arbor, MI. GreenMark CEO Dr. Steven Bloembergen presented in the afternoon investor pitch session. The Center has funded GreenMark Biomedical through its NIH/NIDCR grant program since 2018 on […]
Read More